-
News | 2025.12.18
Winter viruses: viral families, common illnesses and at-risk populations
Several pathogens have adapted to winter conditions and circulate on a seasonal basis in the northern hemisphere. These include seasonal influenza viruses, currently under heightened surveillance; viruses responsible for bronchiolitis in infants; and coronaviruses. Only a handful of the hundreds of respiratory and stomach viruses in circulation cause significant winter epidemics.
-
Fiche maladie | 2023.11.27
Dengue
Dengue, also known as ‘tropical flu’, is an infectious disease caused by the virus of the same name. The virus is transmitted by mosquitoes of the genus Aedes. The incidence of dengue is rising rapidly and it is currently considered a ‘re-emerging’ disease.
-
Article | 2023.12.18
Interdisciplinary Training in Genomic Epidemiology and Public Health Bioinformatics
This interdisciplinary programme, funded by ECDC, combines lectures and practical sessions delivered by multiple host institutions in order to enhance surveillance, preparedness, and readiness to respond to outbreaks.
-
News | 2022.06.08
The role of social sciences in the response to an epidemic: the example of the COVID-19 pandemic
A lesser known but equally crucial dimension in managing and responding to an epidemic is social sciences in health, which can shed light on populations' understanding, perception and acceptance of the risks associated with diseases. The COVID-19 pandemic is no exception. As the disease spread across the planet, clear differences in perception by populations were observed in different countries,...
-
Document de presse | 2012.09.26
Malaria Takes a Hit – Two New Molecules Stop P. falciparum in its Tracks
Researchers at the Institut Pasteur and the French National Center for Scientific Research (CNRS), in collaboration with Imperial College London, have synthesized two molecules capable of quickly and irreversibly stopping the growth of P. falciparum at every blood stage of its life cycle. These molecules work by inhibiting the histone methyltransferase enzymes necessary for the parasite’s...
-
Document de presse | 2005.10.12
Institut Pasteur and Total join forces to combat infectious diseases
On October 13, Total and Institut Pasteur signed a corporate funding agreement intended to strengthen the scientific and human resources allocated to the fight against infectious diseases, especially sexually transmitted diseases (STD). The five-year agreement covers two areas. Press release Paris, october 13, 2005 · Support for Institut Pasteur’s research...
-
News | 2016.10.20
Table salt to diagnose malaria
At the Centre Pasteur in Cameroon, the International Four Year Group (G4) on malaria created in 2013 is developping a diagnostic test working with common table salt. Dr. Lawrence Ayong, head of the group explains how this innovative tool works as well as his ambitious research program on malaria.Dr Lawrence Ayong, Responsable du laboratoire de recherche sur le paludisme au Centre Pasteur du...
-
News | 2018.04.11
New Pasteur-USP Scientific Platform in Brazil to tackle neurological disorders with a one health approach
A group of scientists are in the process of setting up the first crew of a research taskforce in Brazil, spawn of the University of São Paulo/Institut Pasteur /Fiocruz tripartite agreement signed in 2015. This scientific platform will focus on neurological disorders caused by either infectious agents or as a consequence of degenerative/progressive diseases. Both causes are growing problems in...
-
News | 2019.01.28
Insecticide resistance genes affect vector competence for West Nile virus
In a context of overuse of insecticides, which leads to the selection of resistant mosquitoes, it is already known that this resistance to insecticides affects interactions between mosquitoes and the pathogens they transmit. Researchers from the Institut Pasteur (Paris) and its partners prove that mechanisms of insecticide resistance, observed in Culex quinquefasciatus vector, impact the...
-
News | 2019.04.03
Discovery of a restriction factor for hepatitis B virus
Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. Although there is a vaccine that offers protection against the virus, current treatments which prevent the virus from replicating are not curative for infected individuals. Scientists at the Institut Pasteur working in collaboration with the CNRS have demonstrated that a cellular protein is capable of acting as a...